Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2023-12-11 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares (buybacks) with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is a regulatory disclosure about share capital changes and repurchases, not a financial report or earnings release. It is a formal notification of share capital changes and buybacks, fitting the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transactional data, confirming it is not a mere announcement but a full disclosure report of share transactions by the company.
2023-12-11 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed tables of repurchase of shares (buybacks) with dates and quantities, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a financial report or earnings release. It is not an announcement of a report publication but a substantive disclosure of share transactions by the company. This fits the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-12-08 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed listings of repurchase of shares (buybacks) with dates and quantities, referencing compliance with the Main Board Listing Rules and GEM Listing Rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase transactions and changes in issued share capital, which aligns with announcements regarding share buybacks or capital changes. There is no indication of financial statements, management discussion, or earnings data. The document is not a report or presentation but a regulatory disclosure of share repurchase activity. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is substantial (15,000 characters), indicating it is a full disclosure rather than a brief announcement or certification.
2023-12-07 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase transactions with dates and quantities, referencing compliance with the Main Board Listing Rules and GEM Listing Rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase activities and changes in issued shares, which aligns with announcements regarding share repurchases or capital changes. The document is lengthy (15,000 characters) and contains substantive data on share transactions, not merely an announcement of a report or a certification. Therefore, it fits best under the category for share repurchase or capital changes rather than a general regulatory filing or report publication announcement.
2023-12-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed listings of repurchase transactions of shares over a period, with dates and quantities. The document references compliance with listing rules of the Hong Kong Stock Exchange and confirms authorization by the board of directors. There is no indication of financial statements, earnings data, or management discussion. The content is focused on reporting share repurchase activity and changes in issued share capital, which aligns with announcements of share buybacks or capital changes. Therefore, the document fits the category of 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed transactional data, supporting a high confidence in classification.
2023-12-05 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, indicating ongoing transactions in the company's own shares. The document references compliance with listing rules and legal requirements related to share issues and repurchases. There is no indication of it being a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure of share capital changes and buybacks. This fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-12-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.